ALLISON MILLER: Open Payments
NPI 1538677497 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,181 in 87 payments from 21 companies in 2025. Trend: 2023 $3,395 · 2024 $4,071 · 2025 $2,181
Food & beverage: $2,181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $938 |
| Amgen Inc. | 4 | $160 |
| Biogen, Inc. | 6 | $141 |
| EMD Serono, Inc. | 2 | $131 |
| TG Therapeutics, Inc. | 1 | $119 |
| UCB, Inc. | 3 | $81 |
| PFIZER INC. | 5 | $81 |
| Amneal Pharmaceuticals LLC | 3 | $74 |
| Grifols USA, LLC | 3 | $68 |
| Lilly USA, LLC | 3 | $58 |
Products named: BOTOX, QULIPTA, BRIUMVI, TYSABRI, VYALEV, Nayzilam, NURTEC ODT, CREXONT.
Industry payments across MO — which companies pay providers there.
